The human visual cortex responds to gene therapy-mediated recovery of retinal function - Wikidata - wikimedia - TriplyDB

The human visual cortex responds to gene therapy-mediated recovery of retinal function

The human visual cortex responds to gene therapy-mediated recovery of retinal function

http://www.wikidata.org/entity/Q24629697

about

Gene therapy: light is finally in the tunnel Gene therapy of inherited retinal degenerations: prospects and challenges Adeno-associated virus-mediated cancer gene therapy: current status Gene Augmentation Therapy Restores Retinal Function and Visual Behavior in a Sheep Model of CNGA3 Achromatopsia Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial.The human rhodopsin kinase promoter in an AAV5 vector confers rod- and cone-specific expression in the primate retina.AAV2 gene therapy readministration in three adults with congenital blindness.Quantitative assessment of visual cortex function with fMRI at 7 Tesla-test-retest variability.Cardiac BNP gene delivery prolongs survival in aged spontaneously hypertensive rats with overt hypertensive heart disease.My career path for developing gene therapy for blinding diseases: the importance of mentors, collaborators, and opportunities.Vector platforms for gene therapy of inherited retinopathies.Recombinant vectors based on porcine adeno-associated viral serotypes transduce the murine and pig retina Pseudo-fovea formation after gene therapy for RPE65-LCA.Spotlight on childhood blindness.Neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma Test-retest, within-visit variability of Goldmann visual fields in retinitis pigmentosa.Capsid Mutated Adeno-Associated Virus Delivered to the Anterior Chamber Results in Efficient Transduction of Trabecular Meshwork in Mouse and Rat An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses Halting progressive neurodegeneration in advanced retinitis pigmentosa Gene therapy of inherited retinopathies: a long and successful road from viral vectors to patients.Plasticity of the human visual system after retinal gene therapy in patients with Leber's congenital amaurosis.Retinal Gene Therapy: Current Progress and Future Prospects.Basic FGF or VEGF gene therapy corrects insufficiency in the intrinsic healing capacity of tendons.AAV-mediated gene therapy in the guanylate cyclase (RetGC1/RetGC2) double knockout mouse model of Leber congenital amaurosis.Adeno-associated virus capsid antigen presentation is dependent on endosomal escape.Let There Be Light: Gene and Cell Therapy for Blindness.Transduction of photoreceptors with equine infectious anemia virus lentiviral vectors: safety and biodistribution of StarGen for Stargardt disease Combined rod and cone transduction by adeno-associated virus 2/8.Advances in gene therapy technologies to treat retinitis pigmentosa.Reprogramming metabolism by targeting sirtuin 6 attenuates retinal degeneration.fMRI of retina-originated phosphenes experienced by patients with Leber congenital amaurosis.Insights from Genetic Model Systems of Retinal Degeneration: Role of Epsins in Retinal Angiogenesis and VEGFR2 Signaling.Correction of Monogenic and Common Retinal Disorders with Gene Therapy.Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial.Viability of long-term gene therapy in the cochlea.Targeting co-stimulatory pathways in gene therapy Gene therapy for Leber congenital amaurosis: advances and future directions.Progress in gene therapy for neurological disorders.Accounting for linkage disequilibrium in association analysis of diverse populations.Gene replacement therapy for genetic hepatocellular jaundice.

P2860

Q27000091-C9555946-F5BB-44F2-A817-6D437F2E67A5 Q27009261-E6EC9833-DD02-4D33-9192-A53355CCCB6F Q27026177-E2FB8A9E-72AD-442D-A872-7F75875935FA Q27318262-BD02425C-DA0E-4551-8D53-126BECA22376 Q30277652-3CE30237-B435-4F78-875E-E24FFE0D2CA9 Q30525669-39313A6F-7D67-44D4-B65F-5D564CC52763 Q30587265-55D049FF-573C-4089-B2E0-512D08E22834 Q30663008-B2A6822E-C955-4119-8D63-D97FA8640E12 Q33657331-B6CEEE97-6951-44E2-9628-C9552ADDF99C Q34063520-6294371B-5600-4F94-A1D3-FF257C5FA0AD Q34561531-38D0E7F5-5E0F-443D-BCF6-CE1994E1272F Q34631983-F2AF8942-BA22-470F-B559-DE01F66746EA Q34999841-82C07124-A8D7-4B77-9231-A99DE91F5BC1 Q35015829-5ED7D609-D7E8-4F19-AE99-2FAAB1E7D7A7 Q35063022-8B496356-E56F-446C-A0F9-C1A02B9140CF Q35522172-FDD3BF1C-9EC6-4D02-A105-E61EF7BCE2F3 Q35656153-2D21836D-DEA2-489F-8182-26B03567C5D1 Q35920744-A7F2FEA4-21B6-49C5-AA84-9E914CCA891F Q36106057-E75EF48D-9F22-45B2-ABFF-CB2ECF6DBFBC Q36147481-40D71C57-D0ED-43CC-9BD5-0A79C1F8AC62 Q36198173-C1C70615-7C65-4763-A30E-D3ABA566DB65 Q36306263-938DF2F9-1C10-4B90-8FA6-9DA7DE5B33BB Q36569445-7F3EAD5E-10B4-427A-AF39-022FCBBB0729 Q36635482-5F4B68E9-2800-4533-8438-5966CA37ACC4 Q36638203-9AF738DE-44E5-4178-906F-9D2348A2F560 Q36654534-18EB4F3D-052E-439D-8D1B-24ADE8957C79 Q36926064-89D848EB-83E1-4480-B5BB-6961AD9ADEDD Q37404344-D1471AEA-7CE9-4FF9-B21D-643746212131 Q37427526-AB4D4C0B-872F-438E-AA62-62DD0334A6C6 Q37452246-D76A02EA-7102-4A47-989C-2D0949FD4ED9 Q37500055-C940466F-C9FD-48A9-A965-B4A1455884CC Q37636830-7C20FBFD-E21F-470C-9DED-813CB02A14D3 Q37676230-CB760C24-2061-4106-9571-13B3EE07F715 Q37701838-0F428ACC-0C47-4B4A-B818-58CA71B77006 Q37714743-DD10927F-FFB8-4302-9F7A-59314BA60A82 Q37951935-70383478-F4DC-4188-BB18-77F8D665AB3F Q38014265-486E14E8-205B-4ED8-9B41-F80A4322E1E8 Q38100997-B4EF4E0B-C9A1-431D-8B32-AF30B5B6B792 Q38181995-E338CB39-E68C-48C0-BB58-489FC85B8185 Q38260248-5F6BB384-E736-458C-A8D8-66B6EAEB6C05

P2860

The human visual cortex responds to gene therapy-mediated recovery of retinal function

http://www.wikidata.org/entity/Q24629697

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

The human visual cortex responds to gene therapy-mediated recovery of retinal function

@ast

The human visual cortex responds to gene therapy-mediated recovery of retinal function

@en

The human visual cortex responds to gene therapy-mediated recovery of retinal function

@nl

type

label

The human visual cortex responds to gene therapy-mediated recovery of retinal function

@ast

The human visual cortex responds to gene therapy-mediated recovery of retinal function

@en

The human visual cortex responds to gene therapy-mediated recovery of retinal function

@nl

prefLabel

The human visual cortex responds to gene therapy-mediated recovery of retinal function

@ast

The human visual cortex responds to gene therapy-mediated recovery of retinal function

@en

The human visual cortex responds to gene therapy-mediated recovery of retinal function

@nl

P1433

Q24629697-EFB0E247-33AD-447C-A406-09F395A0F483

P1476

Q24629697-74F40AC2-A238-49D4-83D0-75D8996D5B2D

P2093

Q24629697-131DA5FE-2CC7-4253-B117-82B67145C0F4

Q24629697-3C0CEF0A-EC38-4301-A32F-2148F9B4A2F2

Q24629697-4EB1EAA6-C1A4-4DC5-BDDE-D2C887F5B886

Q24629697-62B5CC42-09E8-4B44-AD03-9861B1E96E1C

Q24629697-6BBFEE0D-1424-45AD-BF43-82ABEF77C3B3

Q24629697-728B1ED3-64EE-4432-8902-EB7D0B1F0716

Q24629697-75081215-ADD5-45B0-828B-628735C2D2E9

Q24629697-9C41CA47-D604-434E-B0CD-7F0130949722

Q24629697-BAD05886-AFC9-47D1-A8BE-CD1E3EC982C6

Q24629697-F1806C35-8952-4742-8A85-D62A946E831F

P2860

Q24629697-020CE2E3-B425-4069-A510-4165DD6B1605

Q24629697-059E3F42-8CA2-4C7D-97BE-C87761E90315

Q24629697-0BF0E75F-EBD5-4763-89E3-002382FE9888

Q24629697-1642F9DA-3737-485E-AE78-1A662733C7C7

Q24629697-1FF540A3-BB4E-402E-8261-FDAC46431CA0

Q24629697-202A0190-7669-4B2C-BF50-0FBE0327630F

Q24629697-2D86A6F9-0766-40AC-913B-8ABACCB41FB0

Q24629697-357590CE-759B-42DD-8C34-C0DF7F6F347F

Q24629697-35FDB08C-317D-42D5-9CCD-2853751634AD

Q24629697-411151FB-E37B-4B45-AA3D-9A5A30ADFB16

P304

Q24629697-F4EC5EDC-2FA1-4D21-A7DD-88A9BC272D62

P31

Q24629697-17FEC61A-11C0-483F-B8C9-A96AE2701662

P356

Q24629697-9EF99B4A-72AA-4290-B8CA-4869CDDDD3AE

P407

Q24629697-FD7B2F8A-1EAC-4A8E-9D69-EFFE8F16C670

P433

Q24629697-63F1E3C3-D605-45CF-AF99-C4C490C68FFE

P478

Q24629697-58EC18A8-9E18-42F6-AF31-AC416998C8C6

P577

Q24629697-15902C2E-AC64-41E5-AFA3-7353C58B07B4

P698

Q24629697-E16CC1ED-6892-4325-9348-A884BA94B134

P921

Q24629697-D400F3E9-00F7-4964-A6C9-2E9036B9E699

P932

Q24629697-1118C4DF-8E7F-4074-BF86-630B346106F3

P356

P1433

Journal of Clinical Investigation

P1476

The human visual cortex responds to gene therapy-mediated recovery of retinal function

@en

P2093

Albert M Maguire

http://www.w3.org/2001/XMLSchema#string

Alberto Auricchio

http://www.w3.org/2001/XMLSchema#string

Bart P Leroy

http://www.w3.org/2001/XMLSchema#string

Daniel C Chung

http://www.w3.org/2001/XMLSchema#string

Francesca Simonelli

http://www.w3.org/2001/XMLSchema#string

Jean Bennett

http://www.w3.org/2001/XMLSchema#string

Justin F Monroe

http://www.w3.org/2001/XMLSchema#string

Kathleen A Marshall

http://www.w3.org/2001/XMLSchema#string

Kenneth S Shindler

http://www.w3.org/2001/XMLSchema#string

Laura L Cyckowski

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy

Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial

Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration

Safety and efficacy of gene transfer for Leber's congenital amaurosis

Thresholding of statistical maps in functional neuroimaging using the false discovery rate

Mutations in RPE65 cause Leber's congenital amaurosis

Leber congenital amaurosis - a model for efficient genetic testing of heterogeneous disorders: LXIV Edward Jackson Memorial Lecture

Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial

The human visual cortex

Effect of gene therapy on visual function in Leber's congenital amaurosis

P304

2160-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI57377

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21606598

http://www.w3.org/2001/XMLSchema#string

P921

P932

3104779

http://www.w3.org/2001/XMLSchema#string